Note – a revised version of this Short Report (Version 2) was published on 8th June 2022, to correct an error on page 7:
“Among the 1,124 patients with stomach cancer who were classified as having an EB regimen, there were 199 who were prescribed the 30 Gy/10F regimen recommended for oesophageal tumours.”